4//SEC Filing
Pacira Pharmaceuticals, Inc. 4
Accession 0001209191-17-040678
$PCRXCIK 0001396814operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 8:02 PM ET
Size
7.7 KB
Accession
0001209191-17-040678
Insider Transaction Report
Form 4
Jones James B
SVP & Chief Medical Officer
Transactions
- Award
Common Stock
2017-06-14+7,500→ 17,313 total - Award
Stock Option (Right to Buy)
2017-06-14+15,000→ 15,000 totalExercise: $44.20Exp: 2027-06-14→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira Pharmaceuticals, Inc.
CIK 0001396814
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001396814
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 8:02 PM ET
- Size
- 7.7 KB